| Literature DB >> 21994835 |
Grace Lindsay1, Kathryn Inverarity, Joan R S McDowell.
Abstract
Objectives. To evaluate changes in health related quality of life (HRQL) for individuals with Type 2 diabetes following the introduction of a new community-based model of care. Methods. A survey method was used in which HRQL, Problems Areas In Diabetes (PAID) and demographics were assessed before and 18 months after introducing the new service. Results. Overall HRQL and PAID scores were lower than published levels in individuals with diabetes but remained stable during the transition to the new model of care except for the bodily pain domain and deteriorating PAID scores for older patients. Four domains of SF36 health showed deterioration in the highest socio-economic groups. Deterioration was also observed in males, most notably mental health, in patients aged 54 years or less, 75 years or more and patients from socio-economic groups 1 and 2. HRQL was lowest at baseline and follow-up in socio-economic groups 6 & 7. Low levels of distress in patients across all deprivation categories was observed but remained stable over the transition. Conclusions. HRQL and distress associated with diabetes remained stable following the introduction of the new community-based model of care except for deterioration in the bodily pain domain and deteriorating PAID scores for older patients. Relevance for Practice. (i) Health related quality of life assessment is practical and acceptable to patients. (ii) In clinical governance terms it is good practice to monitor the impact of change in service delivery on the health of the patients in your care. (iii) Screening with health related quality of life tools such as generic and disease specific tools could help identify health problems otherwise undetected within current clinical care. Systematic identification of the most vulnerable groups with Type 2 diabetes should allow care to be better targeted.Entities:
Year: 2011 PMID: 21994835 PMCID: PMC3169843 DOI: 10.1155/2011/613589
Source DB: PubMed Journal: Nurs Res Pract ISSN: 2090-1429
Comparisons of key differences in approaches between the secondary care focussed model of care to a community model of care for patients with Type 2 diabetes.
| Parameter | Previous | New model |
|---|---|---|
| Setting of diabetes care | Hospital based (secondary care) | General practitioner surgery (Primary care) |
|
| ||
| Access to care | Mixed community/secondary care | Community |
|
| ||
| Structure | IT systems | IT systems to support annual review, recall, and management systems introduced |
|
| ||
| Care provided | Annual Screening and review of clinical parameters | Annual screening and review of clinical parameters |
|
| ||
| Laboratory results sent onto GP with recommendations for action | GP receives laboratory results directly and acts accordingly | |
|
| ||
| Recommendations to GP for change in prescriptions | GP alters prescriptions and initiates necessary therapies | |
|
| ||
| Review by dietitian, podiatrist, and diabetes specialist nurse at annual review that may require considerable waiting times | Review by dietitian, podiatrist, and practice nurse at annual review as part of a one stop shop so no waiting between professionals | |
|
| ||
| Management of diabetes and related risk factors | Management of diabetes, related risk factors within a holistic context | |
|
| ||
| Referral to specialist services as required for example, renal physicians | Referral to specialist services as required for example, renal physicians | |
|
| ||
| Educational preparation | Staff have significant clinical expertise in diabetes with or without recognised qualifications | Staff all required to undertake a credit-rated qualification in diabetes |
|
| ||
| Retinal screening | Secondary care | National level directed |
Comparison of patient demographic details between the research sample and the local health cooperative (LHCC) population of patients with Type 2 diabetes*.
| Patient numbers with Type 2 diabetes in the LHCC and the research sample | Total patient population in the LHCC with Type 2 diabetes | Research sample | LHCC patient population with Type 2 diabetes (excluding research sample) |
|
|---|---|---|---|---|
| Total Number | 1402 | 136 | 1266 | — |
|
| ||||
| Gender | .10 | |||
| Female | 662 (47%) | 55 (40%) | 607 (48%) | |
| Male | 740 (53%) | 81 (60%) | 659 (52%) | |
|
| ||||
| Mean age (SD dev) in years | 63.76 (13.59) | 65.38 (11.96) | 63.57 (13.75) | .08 |
|
| ||||
| Age Category |
| |||
| <55 yrs | 346 (25%) | 28 (21%) | 318 (25%) | |
| 55–64 yrs | 324 (23%) | 23 (17%) | 303 (24%) | |
| 65–74 yrs | 415 (30%) | 56 (41%) | 357 (28%) | |
| >74 yrs | 317 (23%) | 29 (21%) | 288 (23%) | |
|
| ||||
| Deprivation category |
| |||
| 1 | 38 (3%) | 3 (2%) | 35 (3%) | |
| 2 | 260 (19%) | 27 (20%) | 233 (18%) | |
| 3 | 160 (11%) | 26 (19%) | 134 (11%) | |
| 4 | 252 (18%) | 32 (24%) | 220 (17%) | |
| 5 | 85 (6%) | 8 (6%) | 77 (6%) | |
| 6 | 187 (13%) | 11 (8%) | 176 (14%) | |
| 7 | 420 (30%) | 29 (21%) | 391 (31%) | |
|
| ||||
| Grouped dep cat |
| |||
| 1 and 2 | 268 (21%) | 30 (22%) | 268 (21%) | |
| 3, 4 & 5 | 431 (34%) | 66 (49%) | 431 (34%) | |
| 6 & 7 | 567 (45%) | 40 (29%) | 567 (45%) | |
|
| ||||
| Ethnic origin |
| |||
| Asian | 254 (18%) | 8 (6%) | 246 (19%) | |
| Other | 1148 (82%) | 128 (94%) | 1020 (81%) | |
*Chi Squared statistics were used to compare differenced in frequencies.
Health-related quality of life scores: SF-36 by whole group and by gender before and 18 months after introduction of the new community model of care for people with Type 2 diabetes compared with other diabetic population groups (12).
| SF-36 domains | SF 36 scores (9) | Whole group | Males | Females |
|---|---|---|---|---|
|
| 541 | 88 | 52 | 36 |
|
| ||||
| Baseline/followup | B F | B F | B F | |
|
| ||||
| Physical function | 67.7 | 75 versus 70 | 75 versus 78 | 73 versus 63 |
|
|
|
| ||
|
| ||||
| Role limitation physical | 56.8 | 75 versus 50 | 100 versus 75 | 50 versus 25 |
|
|
|
| ||
|
| ||||
| Role limitation mental | 75.6 | 88 versus 100 | 100 versus 100 | 67 versus 100 |
|
|
|
| ||
|
| ||||
| Social function | 82.0 | 89 versus 78 | 89 versus 78 | 78 versus 78 |
|
|
|
| ||
|
| ||||
| Mental health | 76.8 | 72 versus 70 | 75.4 versus 71.2 | 66.1 versus 67.7 |
|
|
|
| ||
|
| ||||
| Energy/vitality | 55.7 | 51 versus 49 | 54.1 versus 49.9 | 47.5 versus 47.4 |
|
|
|
| ||
|
| ||||
| Bodily pain | 68.5 | 70 versus 63.9 | 72.5 versus 67.4 | 67.3 versus 59.0 |
|
|
|
| ||
|
| ||||
| General health | 56.1 | 54.8 versus 51.7 | 55.8 versus 51.1 | 53.4 versus 52.6 |
|
|
|
| ||
Health-related quality of life scores: SF-36 before and 18 months after introduction of the new community model of care for people with Type 2 diabetes by age groupings and deprivation category. Statistical comparisons of baseline and follow-up data, when these data are not normally distributed, are based on the Mann-Whitney-Wilcoxon rank test.
| SF-36 domains | Age <55 years | Age 55–64 years | Age 65–74 years | Age >74 years | Dep cat 1&2 | Dep cat 3, 4 & 5 | Dep cat 6 & 7 |
|---|---|---|---|---|---|---|---|
|
| 15 | 17 | 39 | 17 | 24 | 41 | 23 |
|
| |||||||
| Baseline/followup | B F | B F | B F | B F | B F | B F | B F |
|
| |||||||
| Physical function | 75 versus 80 (55–100) | 75 versus 80 (43–90) | 75 versus 70 (50–90) | 65 versus 45 (45–78) | 75 versus 75 | 75 versus 75 | 50 versus 45 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Role limitation physical | 100 versus 50 (0–100) | 100 versus 100 (13–100) | 50 versus 50 (0–100) | 50 versus 0 (13–100) | 100 versus 50 | 100 versus 100 | 25 versus 0 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Role limitation mental | 100 versus 33 (0– 100) | 100 versus 100 (46–100) | 67 versus 100 (33–100) | 100 versus 67 (17–100) | 100 versus 100 | 75 versus 100 | 57 versus 33 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Social function | 89 versus 67 (33–100) | 89 versus 78 (56–100) | 89 versus 89 (67–100) | 78 versus 67 (62–95) | 100 versus 89 | 89 versus 89 | 67 versus 56 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Mental health | 59.5 versus 56.3 | 66.8 versus 67.5 | 75.3 versus 73.6 | 78.6 versus 74.8 | 81.0 versus 77.5 | 70.7 versus 70.6 | 63.3 versus 60.0 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Energy/vitality | 41.7 versus 41.3 | 52.4 versus 52.4 | 52.1 versus 51.2 | 57.7 versus 46.8 | 62.7 versus 54.4 | 51.1 versus 50.2 | 40.2 versus 40.7 |
|
|
|
|
|
|
|
| |
|
| |||||||
| Bodily pain | 68.3 versus 57.9 | 66.1 versus 68.1 | 70.4 versus 65.3 | 76.5 versus 62 | 79.3 versus 67.6 | 70.5 versus 67.3 | 60.9 versus 54.2 |
|
|
|
|
|
|
|
| |
|
| |||||||
| General health | 50.3 versus 41.4 | 52.3 versus 55.8 | 56.7 versus 54.0 | 56.8 versus 51.5 | 64.1 versus 55.1 | 55.6 versus 53.6 | 43.6 versus 44.7 |
|
|
|
|
|
|
|
| |
Health-related quality of life scores: PAID questionnaires before and 18 months after introduction of community model of care for people with Type 2 diabetes.
| Domain | Whole group | Males | Females | Age <55 years | Age 55–64 years | Age 65–74 years | Age >74 years | Dep cat 1 & 2 | Dep cat 3, 4 & 5 | Dep cat 6 & 7 |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 88 | 52 | 36 | 15 | 17 | 39 | 17 | 24 | 41 | 23 |
|
| ||||||||||
| Baseline/ followup | B F | B F | B F | B F | B F | B F | B F | B F | B F | B F |
|
| ||||||||||
| PAID | 13 versus 13 | 12 versus 13 | 13 versus 13 | 25 versus 23 | 16 versus 13 | 10 versus 11 | 6 versus 9 | 9 versus 9 | 13 versus 14 | 14 versus 13 |
|
|
|
|
|
|
|
|
|
|
| |
Figure 1Baseline PAID score and follow-up PAID score versus age. *statistically significant difference with P = .045. **statistically significant difference with P = .020.